マルブルクウイルスのヒト抗体媒介による中和のメカニズム
Andrew I Flyak1, Philipp A Ilinykh2, Charles D Murin3
1Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232, USA.
Cell
|February 28, 2015
まとめ
研究者らは,マーブルクウイルス (MARV) の生存者からの中和抗体を特定し,MARVグリコプロテインを標的とした. これらの抗体は,暴露された受容体結合部位に結合することで,MARVを抑制し,フィロウイルス抑制のための新しいメカニズムを提供します.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- 免疫学 免疫学とは
- 構造生物学 構造生物学とは
背景:
- 中和抗体がマルブルクウイルス (MARV) を抑制する正確なメカニズムは,ほとんど不明のままです.
- これらのメカニズムを理解することは,フィロウイルスに対する効果的な抗ウイルス治療の開発に不可欠です.
研究 の 目的:
- マルブルクウイルス (MARV) に対する中和抗体の作用メカニズムを解明する.
- MARV特異的中和抗体の結合部位と構造的相互作用を特徴付ける.
主な方法:
- MARVの生存者からの中和抗体の分離と特徴付け.
- MARVおよびエボラウイルス (EBOV) のグリコプロテイン (GP) との抗体相互作用を評価するための拘束力のある測定法.
- 単粒子の冷凍電子顕微鏡 (cryo-EM) で,抗体-GP複合体の構造を決定する.
主要な成果:
- MARVグリコタンパク質 (GP) を標的とする中和抗体のパネルが特定され,すべて1つの主要な抗原部位に結合しました.
- いくつかの抗体は,エボラウイルス (EBOV) GPとのクロス反応性を示した.
- Cryo-EMでは,中和抗体が,受容体結合部位の近くにあるMARV GPに結合することを明らかにした.これは,グリカンキャップとムシンのようなドメインにもかかわらずアクセス可能な部位である.
- MARV GPとは異なり,EBOV GPの結合は,そのグリカンキャップとムシンのようなドメインによって妨げられました.
結論:
- MARV中和抗体は,感染性ウィリアンの暴露された受容体結合部位に結合することによって,ウイルスを抑制します.
- この結合メカニズムは,フィロウイルス抑制のための新しい戦略を表しています.
- EBOV GPと比較してMARV GP受容体結合部位の独特のアクセシビリティは,抗体中和の有効性に影響します.
関連する概念動画
Antibody Actions
4.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
4.1K
Humoral Immune Responses
87.9K
Overview
87.9K
Immune Response Against Viral Pathogens
2.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.7K
Antibody Structure
69.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
69.4K
Antibody Structure and Classes
10.5K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.5K
Cross-reactivity
34.0K
Overview
34.0K


